Tunstall Partners with NHS Gloucestershire in Clinically-led Long Term Conditions Management Programme

Tunstall HealthcareTunstall Healthcare has partnered with NHS Gloucestershire, the primary care trust for Gloucestershire, to implement a large-scale telehealth programme to support the management of long term conditions.

This large-scale telehealth programme aims to provide a managed system of care and response, targeted at patients with long term conditions for whom a timely response will help manage their short and medium term care needs, therefore improving patient outcomes and helping reduce the number of hospital admissions.

Gloucestershire has a population of more than 600,000 people with approximately 6,000 of those people living with a long-term condition (LTC). The use of telehealth complements the changing nature of healthcare to provide care in the right place at the right time and, having run a small scale initiative, NHS Gloucestershire is keen to tap into the expertise of Tunstall to roll out a much larger project to support local people.

The partnership will see Tunstall work with local clinicians across both secondary and primary care to redesign care pathways and implement clinical protocols which will see telehealth as a viable option for managing patients.

As part of the programme, the provision of telehealth will be extended to 2,000 patients with chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), chronic heart disease (CHD) and diabetes.

Dr Will Haynes, a Gloucester-based GP and practice-based commissioning lead for Gloucester who is working closely with Tunstall on this project, said: "The widespread use of telehealth technology will complement other developments across the NHS in Gloucestershire to help reduce referrals to hospitals, help more patients to receive their care within, or as close to, home as possible and help more patients to understand better and self manage their own conditions, within the safety and fabric of telehealth monitoring. As a GP, I welcome the opportunity to use these tools to work with patients to understand their condition."

The provision of telehealth will be extended over a 12-month period commencing in Summer 2011, following a comprehensive, clinically-led development process with Tunstall and Ernst & Young providing full project management and a detailed care pathway redesign programme.

Jon Lowe, Tunstall's Managing Director said: "We are extremely pleased to be working in a strategic partnership with such an innovative team. We are committed to ensuring this large-scale managed telehealth service is a success and I am confident that patients and clinicians will benefit greatly in the future."

Related news articles:

About Tunstall
Tunstall Healthcare Group is the market-leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall’s solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...